This year, the Lasker Foundation confers its Clinical Medical Research Award on Akira Endo for his isolation from fungi of statins, potent inhibitors of cholesterol synthesis in the liver. The introduction of statins to clinical practice has markedly reduced morbidity and mortality from atherosclerotic cardiovascular disease
Statins represent the cornerstone for the treatment of hypercholesterolemia, although muscle-related...
Statins [3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase], are wonder drugs that have resh...
Anti-inflammatory activities of statins in atherosclerosis have been well documented by both basic r...
This year, the Lasker Foundation confers its Clinical Medical Research Award on Akira Endo for his i...
Lasker award in 2008, identified a fungal metabolite that blocked cholesterol synthesis by inhibitin...
This article contains information from a talk given by the author at the RMS on 14/01/03, entitled: ...
The discovery of the statins was a great success in car-diovascular research and pharmaceuticals dev...
AbstractSignificant advances in the management of cardiovascular disease have been made possible by ...
More than 100,000 people have participated in controlled trials of statins (lowering cholesterol dru...
SummaryStatins have been shown to reduce cardiovascular events across a broad spectrum of patients a...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Statins reduce cholesterol biosynthesis by inhibiting HMG-CoA reductase and thereby lower total chol...
Large scale clinical trials demonstrate significant reductions in cardiovascular event rates with st...
The basic pathological change of coronary heart disease is atherosclerosis, and the main risk factor...
Alberto Corsini, Nicola Ferri, Michele CortellaroDepartment of Pharmacological Sciences and Departme...
Statins represent the cornerstone for the treatment of hypercholesterolemia, although muscle-related...
Statins [3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase], are wonder drugs that have resh...
Anti-inflammatory activities of statins in atherosclerosis have been well documented by both basic r...
This year, the Lasker Foundation confers its Clinical Medical Research Award on Akira Endo for his i...
Lasker award in 2008, identified a fungal metabolite that blocked cholesterol synthesis by inhibitin...
This article contains information from a talk given by the author at the RMS on 14/01/03, entitled: ...
The discovery of the statins was a great success in car-diovascular research and pharmaceuticals dev...
AbstractSignificant advances in the management of cardiovascular disease have been made possible by ...
More than 100,000 people have participated in controlled trials of statins (lowering cholesterol dru...
SummaryStatins have been shown to reduce cardiovascular events across a broad spectrum of patients a...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Statins reduce cholesterol biosynthesis by inhibiting HMG-CoA reductase and thereby lower total chol...
Large scale clinical trials demonstrate significant reductions in cardiovascular event rates with st...
The basic pathological change of coronary heart disease is atherosclerosis, and the main risk factor...
Alberto Corsini, Nicola Ferri, Michele CortellaroDepartment of Pharmacological Sciences and Departme...
Statins represent the cornerstone for the treatment of hypercholesterolemia, although muscle-related...
Statins [3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase], are wonder drugs that have resh...
Anti-inflammatory activities of statins in atherosclerosis have been well documented by both basic r...
DOI
Add to ORKG